Overview

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults

Status:
Completed

Trial end date:
2004-02-01

Target enrollment:

Participant gender:

Summary

The objectives of the study were to confirm that a single, 2.0-g dose of azithromycin sustained release (SR) was at least as effective to 10 days of oral levofloxacin 500 mg once a day, when used to treat adults with uncomplicated, acute bacterial sinus infections, and to evaluate the safety of both treatments.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Azithromycin
Levofloxacin
Ofloxacin